Attenuation of Vibrio parahaemolyticus Virulence Factors by a Mixture of Natural Antimicrobials. by Pinkerton, Laurette et al.
LSHTM Research Online
Pinkerton, Laurette; Linton, Mark; Kelly, Carmel; Ward, Patrick; Gradisteanu Pircalabioru,
Gratiela; Pet, Ioan; Stef, Lavinia; Sima, Filip; Adamov, Tabita; Gundogdu, Ozan; +1 more...
Corcionivoschi, Nicolae; (2019) Attenuation of Vibrio parahaemolyticus Virulence Factors by a
Mixture of Natural Antimicrobials. Microorganisms, 7 (12). p. 679. ISSN 2076-2607 DOI:
https://doi.org/10.3390/microorganisms7120679
Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4655564/
DOI: https://doi.org/10.3390/microorganisms7120679
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
microorganisms
Article
Attenuation of Vibrio parahaemolyticus Virulence
Factors by a Mixture of Natural Antimicrobials
Laurette Pinkerton 1,†, Mark Linton 1,†, Carmel Kelly 1, Patrick Ward 2,
Gratiela Gradisteanu Pircalabioru 3, Ioan Pet 4, Lavinia Stef 4, Filip Sima 1,2,3, Tabita Adamov 4,
Ozan Gundogdu 5,* and Nicolae Corcionivoschi 1,2,4,*
1 Bacteriology Branch, Veterinary Sciences Division, Agri-Food and Biosciences Institute, Belfast BT9 5PX, UK;
laurette.pinkerton@afbini.gov.uk (L.P.); mark.linton@afbini.gov.uk (M.L.); carmel.kelly@afbini.gov.uk (C.K.);
filip.sima@afbini.gov.uk (F.S.)
2 Auranta, NovaUCD, Dublin 4, Ireland; pat@auranta.ie
3 Research Institute of University of Bucharest, 300645 Bucharest, Romania; gratiela87@gmail.com
4 Banat University of Animal Sciences and Veterinary Medicine - King Michael I of Romania,
300645 Timisoara, Romania; ioanpet@eurofins.com (I.P.); Lavi_stef@animalsci-tm.ro (L.S.);
tabitaadamov2003@yahoo.com (T.A.)
5 London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
* Correspondence: Ozan.Gundogdu@lshtm.ac.uk (O.G.); nicolae.corcionivoschi@afbini.gov.uk (N.C.)
† These authors contributed equally to this work.
Received: 18 November 2019; Accepted: 9 December 2019; Published: 11 December 2019 
Abstract: Reducing acute mortality in aquatic crustaceans using natural alternatives to antibiotics
has become a necessity, firstly for its positive impact on the aquaculture industry and, secondly,
because the extensive use of antibiotics may lead to increased levels of drug resistance in pathogenic
microorganisms. This study aimed to investigate the effect of a mixture of natural antimicrobials
on the in vitro and in vivo virulence abilities of Type VI secretion system (T6SS)-positive Vibrio
parahaemolyticus (A3 and D4), strains known as having potentially harmful health consequences for
aquatic crustaceans and consumers. Herein, we report that a natural antimicrobial mixture (A3009)
was capable of significantly reducing the virulence of V. parahaemolyticus strains A3 and D4 in an
in vitro infection model, using the fish cell line CHSE-214, an effect which correlates with the bacterial
downregulation of hcp1 and hcp2 gene expression and with the ability of the antimicrobial to efficiently
retain low cytotoxic levels (p < 0.001). We show for the first time that a natural antimicrobial is able to
significantly reduce the mortality of shrimps in a challenge experiment and is able to significantly
attenuate H2O2 release during infection (p < 0.001), indicating that it could harbor positive intestinal
redox balance effects.
Keywords: Vibrio parahaemolyticus; virulence; natural antimicrobials
1. Introduction
V. parahaemolyticus is a Gram-negative bacterium, halophilic in nature with a typically rigid curve
or straight non-spore forming rod shape [1]. The bacteria of the Vibrio genus are commonly recognised
as inhabitants of fresh and marine waters, with over 100 species being described so far [2]. Bacterial
pathogens commonly elicit an inflammatory response upon infection; however, V. parahaemolyticus has
not been shown to do so [3]. V. parahaemolyticus is a toxin producing bacterium, in which the toxins are
controlled by the genes pirA and pirB and together are responsible for acute hepatopancreatic necrosis
disease (AHPND) [4]. Individually, the toxins appear to be incapable of inducing AHPND and both
genes must be present for induction to take place [5]. This syndrome has proven to be a frequent cause
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of early mortality syndrome (EMS) in the US and many Asian countries [6]. AHPND induces severe
atrophy of aquatic crustaceans [7] and has been responsible for considerable aquaculture production
losses [8]. Studies have endeavoured to determine the causative agent, collectively identifying the
primary pathogen as V. parahaemolyticus [3].
The Type VI secretion systems (T6SS) are associated with severe forms of gastrointestinal diseases
and have been described mostly in Gram-negative bacteria [9]. Bacteria use these secretion systems to
eliminate competing microorganisms by transporting toxins into target bacteria or eukaryotic cells,
leading to a reduction in growth and ultimately death [10]. Coincidentally, the T6SS was first discovered
in Vibrio cholerae [11] and it was characterised by being responsible for the secretion of haemolysin
protein (hcp), an important virulence factor in many bacteria, including Pseudomonas aeruginosa [12].
Infecting human gastrointestinal cells lines (HCT-8) with Campylobacter spp. highlighted that the T6SS
system is involved via the downregulation of hcp gene expression in the reduction of the bacterium’s
ability to adhere and infect in vitro [13]. The same study also showed that the effect was extrapolated
in vivo when chicken broilers where challenged with Campylobacter spp. In V. parahaemolyticus, the hcp
haemolysin signature gene has two proteins, hcp1 and hcp2, which interestingly are expressed under
different growth conditions mainly related to salt concentration (1.5–3% NaCl) [14]. The differential
expression of hcp1 and hcp2 and their dependency on the salt concentration seems to be related to the
ability of the pathogen to compete for a niche, especially in a marine environment, and to enhance
their virulence ability [14].
V. parahaemolyticus detection strategies are continually being developed in an attempt to reduce
the risk of infection via seafood consumption [15,16]. Various other control and prevention measures
have also been proposed to limit the growth of V. parahaemolyticus in contaminated seafood and
prevent potential outbreaks [17]. However, due to its ubiquitous nature in marine environments and
relatively low infectious dose, bacteria-free seafood is seemingly unattainable [18]. Antibiotics such as
tetracycline are used extensively in aquaculture in an attempt to improve food safety [19]. Despite
their efficiency and low cost, antibiotic overuse has become associated with increasing levels of drug
resistance and the establishment of resistance determinants [20]. The large-scale disinfection of water
prior to stocking is a current practice to remove potential pathogens. This practice causes a considerable
ecosystem disturbance by increasing the nutrient availability post-disinfection; destabilising the
microbial community and in turn encouraging environmental re-colonisation with fast-growing
bacteria, such as the pathogenic Vibrio species [21].
This study aimed to investigate how a mixture of natural antimicrobials could regulate the growth
of V. parahaemolyticus strains A3 and D4 in vitro and in vivo and identify the virulence factors involved.
We also aimed to investigate their potential to attenuate V. parahaemolyticus virulence by using sub-lethal
concentrations of the antimicrobial mixture as there is a constant concern that bacteria could also gain
resistance to natural antimicrobials [22].
2. Materials and Methods
2.1. Bacterial and Eukaryotic Cells Lines and Antimicrobials
The Vibrio parahaemolyticus A3 (origin Vietnam) and D4 (origin Mexico) strains were kindly
donated by Kim Orth from the Department of Molecular Biology, University of Texas Southwestern
Medical Center, Dallas, TX, USA. Both strains were routinely cultured in marine Luria–Bertani (MLB)
broth (Luria–Bertani broth containing 1.5% or 3.5% NaCl). The CHSE-214 cells were obtained from
the European Collection of Authenticated Cell Cultures (ECACC). The CHSE-214 cells (ECACC No.
91041114) are a fish cell line derived from Oncorhync hustshawytscha embryos. They were cultured in
minimum essential medium (MEM) (Gibco, Oxford, UK) supplemented with 10% foetal bovine serum
(Life Technologies, Oxford, UK), 2 nM l-glutamine (Corning, Oxford, UK), and an antibiotic/antimycotic
solution (10,000 IU/mL penicillin, 10,000 µg/mL streptomycin and 25 µg/mL amphotericin B). A mixture
of antimicrobials containing lactic acid, E330 citric acid and citrus extract was used. The composition
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(per kg) of the feed material was sodium chloride (1 g) and maltodextrin. The additives (per kg)
were preservatives, including lactic acid and E330 citric acid, and the flavouring was citrus extract.
The analytical constituents (%) were crude ash (0.2%), crude protein (0.84%), crude oils and fats
(10.83%), crude fibre (0.03%), phosphorus (0.01%), sodium (1.12%), calcium (1.34%), lysine (0%) and
methionine (0%). The antimicrobial product (Auranta 3009, Nova UCD, Ireland) was obtained from
Envirotech Innovative Products Ltd.
2.2. Determination of Minimum Inhibitory Concentrations
The minimum inhibitory concentration (MIC) and minimum microbicidal concentration (MBC)
were determined for two strains of acute hepatopancreatic necrosis disease (AHPND)-causing Vibrio
parahaemolyticus, strains A3 and D4. The strains were grown overnight at 37 ◦C in nutrient broth (Oxoid,
Basingstoke, UK) containing 1.5% or 3% NaCl. The resulting stationary phase cultures were diluted
using a nutrient broth containing 1.5% or 3% NaCl, to give a suspension containing approximately
6 log CFU/mL A series of Auranta 3009 solutions were prepared in a nutrient broth containing 1.5%
or 3% NaCl, to give a range of concentrations from 4% down to 0.015625%. One ml of each Auranta
3009 solution was transferred into separate sterile plastic bijou bottles and 1 mL of either strain of
V. parahaemolyticus was added to each bottle. A positive control containing 1 mL of nutrient broth and
1 mL of the 6 log CFU/mL suspension was prepared. The negative control was 2 mL of uninoculated
nutrient broth plus salt. The mixtures were incubated aerobically at 37 ◦C for 24 h. This procedure
was repeated on three separate occasions. The MIC value was determined as the lowest concentration
of Auranta 3009 that showed no bacterial growth. After 24 h, the bijou bottles were observed for
bacterial growth. If the broth was clear, indicating no bacterial growth, then 100 µL was spread-plated
onto nutrient agar containing 1.5% or 3% NaCl using a sterile glass spreader. This was repeated
for all concentrations of Auranta 3009 that appeared clear in the bijou container. All plates were
incubated aerobically at 37 ◦C for 24 h. This procedure was repeated on three separate occasions for
both V. parahaemolyticus strains A3 and D4. The MBC value was determined as the lowest concentration
of Auranta 3009 that showed no bacterial growth on the plates.
2.3. Growth Curves
Growth curves were established for both strains of V. parahaemolyticus; A3 and D4. Broth cultures
were prepared in a nutrient broth containing 1.5% or 3% NaCl and incubated overnight at 37 ◦C.
These were diluted using nutrient broth containing 1.5% or 3% NaCl, to give a final concentration of
approximately 6 log CFU/mL. The MIC value for both V. parahaemolyticus A3 and V. parahaemolyticus
D4 was previously determined to be 0.0625% of Auranta 3009. An Auranta 3009 solution was prepared
using a nutrient broth containing 1.5% or 3% NaCl to give a final concentration of 0.0625% when the
suspension of bacteria was added. Two-fold dilutions of this solution were prepared in a 96-well
plate giving a range of Auranta 3009 concentrations from the MIC (0.0625%) down to 1/8 of the
MIC concentration (0.0078125%). The final volume of Auranta 3009 solution in each well was 90 µL.
The bacterial suspension (10 µL) was added to each well and thoroughly mixed. Nutrient broth
containing 1.5% or 3% NaCl with no Auranta 3009 added was inoculated with the bacterial suspension
as a positive control. The negative control was uninoculated nutrient broth containing 1.5% or 3%
NaCl. The 96-well plate was sealed with plastic film and the optical density was measured at 600 nm
at intervals of 1 h over a 24 h period at 37 ◦C using a FLUOstar Omega automatic plate reader (BGM
Labtech, Aylesbury, UK). This procedure was repeated on three separate occasions for both Vibrio
parahaemolyticus A3 and D4.
2.4. Challenge Tests (Counting Living Larvae)
V. parahaemolyticus strains A3 and D4 were selected to be tested for their pathogenicity by a challenge
test using healthy Penaeus vannamei post larvae, following a procedure previously described [23].
Twenty-five shrimp post larvae per replicate were plated in sterile petri dishes and exposed to infection
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with 109/mL bacteria for 10 min. The antimicrobial mixture was applied at the time of infection in
concentrations of 0.0625%, 0.031%, 0.015% and 0.007% in 500 mL flasks. Survival was determined by
counting the larvae at 30 h after infection. A positive and a negative control (± antimicrobial mixture
or ± larvae) was also included in the challenge at 0% of the antimicrobial mixture. The experiment was
performed in triplicate.
2.5. H2O2 Production in CHSE-214 Cells Response to Treatment Following Infection
A culture mixture of V. parahaemolyticus strains A3 and D4 was prepared as described above.
The CHSE-214 cells were grown in a minimum essential medium (Minimum Essential Media (MEM)
-Gibco®, Waltham, MA, USA) until they reached confluence and were supplemented with 10% fetal
bovine serum and 2 mL glutamine. The cells were routinely grown in 75 cm2 tissue culture flasks
(Sigma-Aldrich, St. Louis, MO, USA), in a humidified incubator at 37 ◦C with 5% CO2. The H2O2
production from infected and un-infected CHSE-214 in response to treatment with Auranta 3009 at was
measured using the PeroxiDetect™ Kit (Sigma-Aldrich, St. Louis, MO, USA), following manufacturer
guidelines and as described in [24].
2.6. In Vitro Adhesion and Infection Assay on CHSE-214 Cell Line and qRT-PCR for hcp1 and hcp2 Expression
To confirm the efficacy of Auranta 3009 in reducing the adhesion and invasion abilities of
V. parahaeomolyticus strains A3 and D4 the isolates were grown to the OD600 of 0.5. The CHSE-214 were
cultured as described above. Prior to the infection of the cells, the cell monolayers were incubated for 3
h with tissue culture media containing 0.031% Auranta 3009 followed by washing three times with
the tissue culture media, and then infected for 3 h with 104 CFU/mL V. parahaemolyticus strains A3
and D4. After infection, the infection media was removed and the infected monolayers were washed
three times with the tissue culture media. The infected cells were then incubated with tissue culture
media containing gentamicin (100 µg/mL) in order to expose the internalised bacteria or to total lysis
without gentamicin inclusion, but, instead, 0.1% Triton X was included to reveal the total bacterial
adhesion. In order to determine the role of hcp1 in marine conditions (3% NaCl), in V. parahaeomolyticus
infection, we have co-cultured the microorganism in nutrient broth containing 1.5% or 3% NaCl in
the presence of 0.031% Auranta 3009 for 3 h. The co-cultured microorganisms were then used in the
infection assay at an MOI of 100. Similarly, the experiment was also performed to investigate the
effect of hcp2 expression, but this time with bacteria grown in low salt concentrations (1.5% NaCl).
The bacteria grown in the above conditions was also used to determine the hcp1 and hcp2 gene
expression in the above conditions. The primers used to detect hcp1 were: cacgtgacggctcggtgg and
ctcttctttcgcgtcttggtcg and for hcp2 cgagtatccactcgaaactttc and ttctgctccctcagtactttctg [14]. The RNA
was reverse transcribed using Transcriptor First Strand cDNA Synthesis Kit (Roche, United Kingdom)
according to the manufacturer’s protocols. The mRNA levels were determined by quantitative RT-PCR
using QuantiNovaSYBR® Green PCR Kit (Qiagen, Manchester, UK) on a LightCycler® 96 (Roche,
Buckinghamshire, UK). A total of 5 µL of SYBR Green master mixture was used in each reaction, along
with 0.5 µL of 10 µM primer mixture, 3 µL of molecular grade water, and 1 µL of DNA sample. For hcp
1 and 2 (2 min at 95 ◦C, followed by 40 cycles of 95 ◦C for 5 s, 60 ◦C for 10 s, and a final extension
at 72 ◦C for 5 min), a total of 5 µL of SYBR Green master mixture was used in each reaction along
with 0.8 µL of 20 µM primer mixture, 7.4 µL of molecular grade water, and 1 µL of DNA sample.
The relative quantity of the mRNA was calculated using the ∆Ct method. The rARN 16S gene was used
as an endogenous control since it was transcribed in equal rates in both the treated and untreated cells.
2.7. Cytotoxicity Assay
The CHSE-214 cells were infected as described above over a 4 h time course with V. parahaemolyticus
strains A3 and D4. The direct impact of Auranta 3009 was investigated by pre-treatment of CHSE-214
cells with 0.031% Auranta 3009 for 3 h. After 3 h, the media was removed, the cells were washed 3×
with fresh MEM, followed by infection with V. parahaemolyticus strains A3 and D4 at an MOI of 100.
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The CHSE-214 cells were also infected with pre-treated bacteria. Uninfected cells exposed to 0.031%
of Auranta 3009 were used as controls. Lactate dehydrogenase release (LDH) was measured with a
cytotoxicity detection kit (Roche, Buckinghamshire, UK) following the manufacturer’s instructions.
The results are expressed as cytotoxicity calculated as a percentage of the total lysis of cells lysed in
Triton X 100.
2.8. Motility Assay
Motility was assessed as previously described [25]. Briefly, cultures of V. parahaemolyticus strains
A3 and D4 were co-cultured in nutrient broth containing 1.5% NaCl or 3% NaCl in the presence of
0.031% Auranta 3009 for 3 h. The co-cultured organisms where then placed (~1 × 106 CFU) at the
centre of the agar plate. The diameter of the motility area was measured. Non-co-cultured strains were
used as a control. The experiments were performed in triplicate and on three separate occasions.
3. Results
3.1. The Role of Antimicrobial Mixtures in the Growth and Survival of V. parahaemolyticus Strains A3 and D4
First, we aimed to gain insight into the growth characteristics of V. parahaemolyticus strains A3 and
D4 in the presence of 1.5% and 3% NaCl. The experiment was designed to identify the concentration
at which the antimicrobial mixture has no lethal effect on the V. parahaemolyticus strains A3 and D4.
This concentration was required to allow us to investigate the possible alteration of bacterial virulence
factors while the pathogens are still alive. The MIC and MBC values at levels of 1.5% and 3% NaCl
against V. parahaemolyticus A3 and V. parahaemolyticus D4 are shown in Table 1. In order to identify the
effect of the antimicrobial mixture on the bacterium virulence factors, we used various concentrations
and identified that at half ratio (1/2) of the highest MBC (0.031%), the antimicrobial mixture had no
lethal effect; however, it disrupted the growth of both strains (Figure 1). Firstly, we have concluded
that the salt concentration had no significant effect on the MIC and MBC values and, secondly, that the
concentration of 0.031% of the antimicrobial mixture can be used further in our investigations to assess
the implications in virulence.
Table 1. MIC and MBC antimicrobial mixture concentrations required for V. parahaemolyticus A3 and
D4 inactivation.
Specification
NaCl (%)
1.5 3
V.p A3 MIC (%) 0.0625 0.0625
MBC (%) 0.0625 0.0625
V.p D4 MIC (%) 0.125 0.0625
MBC (%) 0.5 0.0625
3.2. Motility
We next investigated the potential impact of the antimicrobial mixture on the V. parahaemolyticus
A3 and D4 motility, a major virulence factor, at the sub-inhibitory concentration calculated at half of
the MIC (0.031%) in the presence of 1.5% and 3% NaCl (Figure 2). The motility plate assays clearly
showed that both strains are generally very motile, but the pre-treatment with 0.031% Auranta 3009
significantly reduced motility, independent of the NaCl2 concentration (∗∗∗ p < 0.001). These results
suggested that the antimicrobial mixture reduces the bacterial motility and potentially has an impact
on virulence.
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Figure 1. The impact of A3009 on the growth and survival of Vibrio parahaemolyticus A3 (A)—1.5%
NaCl, (B)—3% NaCl and D4 (C)—1.5% NaCl, (D)—3% NaCl. The MIC concentrations are indicated on
the graphs. The experiments were performed in triplicate and on three separate occasions. In order to
quantify the growth, the absorbance was measured at 600 nm every 0.5 h for 24 h.
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Figure 2. The effect of 0.031% (concentration) Auranta 3009 on V. parahaemolyticus A3 and D4 motility.
Asterisks indicate significant differences (∗∗∗ p < 0.001). Error bars represent the standard deviation of
means from three different experiments, each experiment being performed in triplicate.
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3.3. The Impact of Auranta 3009 on the hcp1 and hcp2 Gene Expression at 1.5% and 3% NaCl
The effect of the antimicrobial mixture on V. parahaemolyticus A3 and D4 hcp gene expression is
shown in Figure 3. The qRT-PCR results indicate a significant downregulation (∗∗∗ p < 0.001) in hcp1
gene expression levels in the presence of 3% NaCl in V. parahaemolyticus A3, with no effect on hcp2 at
this salt concentration. The downregulation effect on hcp2 was only observed in the presence of 1.5%
NaCl, as indicated in Figure 3 (panel A) (∗∗∗ p < 0.001). The results were similar for V. parahaemolyticus
D4 in regard to the downregulation effect on hcp1 (∗∗ p < 0.01) and hcp2 (∗∗∗ p < 0.001) gene expression
produced by Auranta 3009 at 1.5% and 3% NaCl (Figure 3, panel B).
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Figure 3. Effect of the antimicrobial mixture Auranta 3009 on V. parahaemolyticus A3 and D4 hcp1 and
hcp2 gene expression in the presence of 1.5% and 3% NaCl. V. parahaemolyticus A3 (A) and D4 (B).
Asterisks indicate significant differences (Student’s t-test ∗∗ p < 0.01, ∗∗∗ p < 0.001). Error bars represent
the standard deviation of means from three different experiments performed in triplicate.
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3.4. Infection Assay
In order to correlate the negative effect on motility and a possible decrease in virulence,
we performed in vitro infection assays using the CHSE-214 cell line as described in Materials and
Methods. The pre-treatment of V. parahaemolyticus A3 (Figure 4, panel A) and D4 (Figure 4, panel C)
with 0.031% of Auranta 3009 significantly reduced the adherence of both strains (p < 0.001). The impact
on bacterial internalisation was as significant as for adhesion for both strains, as indicated in Figure 5
panel B for V. parahaemolyticus A3 and panel D for V. parahaemolyticus D4 (p < 0.001). When the
antimicrobial mixture was only present in the tissue culture media during the adhesion/invasion assay,
the reductions followed the same pattern (data not shown). These results indicate that the reduced
in vitro infection abilities of V. parahaemolyticus A3 and D4 follow a similar pattern and in concordance
with the reduction in bacterial motility.
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Figure 4. Adhesion and invasion of CHSE-214 cells by V. parahaemolyticus A3 and D4. The adherence
(A) and invasion (B) of V. parahaemolyticus A3 to CHSE214 cells in the presence of Auranta 3009. Panel
C shows the adherence of V. parahaemolyticus D4 and panel D the invasion levels of D4 to CHSE-214
cells. The results are expressed as percentages of the initial inoculum. Asterisks indicate significant
differences (Student’s t-test ∗∗∗ p < 0.001). Error bars represent the standard deviation of means from
three different experiments, each containing triplicate samples.
3.5. Challenge Tests
To estimate the efficiency of the antimicrobial mixture we performed challenge studies by infecting
P. vannamei shrimps with V. parahaemolyticus strains A3 and D4. Our results show that at the MIC/MBC
concentration of the antimicrobial (0.0625%) the lowest shrimp mortality was recorded (Table 2) for
both V. parahaemolyticus strains A3 and D4. The challenge test confirmed the results obtained following
the MIC/MBC and growth curve experiments, indicating the efficiency of the antimicrobial mixture.
The percentage of mortality decreased as the concentration of the antimicrobial mixture increased.
These results clearly indicated that the antimicrobial mixture has potential of protecting the shrimp
cultures in vivo.
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parahaemolyticus A3 (A) and D4 (B) with CHSE-214 cells. The experiments were performed in triplicate
and on three separate occasions. Student t test was used to analyse the impact of Auranta 3009 on
H2O2 release (** p < 0.01).
Table 2. Mortality of Penaeus vannamei after 45 h of challenge after infection with. V. parahaemolyticus
A3 and D4.
Antimicrobial Concentration (%)
Strain
V. parahaemolyticus A3
(% of mortality)
V. parahaemolyticus D4
(% of mortality)
0 98.2 ± 4.3 97.3 ± 2.1
0.0625 2.8 ± 3.3 3.04 ± 1.9
0.031 11 ± 2.2 7.2 ± 4.3
0.015 18 ± 4.3 21 ± 4.4
0.007 38 ± 1.1 46 ± 5.2
3.6. In vitro Epithelial H2O2 Release in Response to Treatment
We ext investigated the impact of V. parahaemolyticus A3 and D4 infection on H2O2 release by
the CHSE-214 in the presence of Auranta 3009. Our results demonstrate that the amount of H2O2
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released in the media during infection is significantly reduced (p < 0.001) by the presence of Auranta
3009 (Figure 5). No effect was identified when the antimicrobial mixture was applied to un-infected
control as the cells released H2O2 levels similar to the control.
3.7. Cytotoxicity
Following exposure to the 0.031% antimicrobial mixture, the infected CHSE-214 cells showed a
clear reduction in cytotoxicity during infection with V. parahaemolyticus A3 (Figure 6, panel A) and D4
(Figure 6, panel B). The cytotoxic levels recorded for infected and un-treated cells reached over 80% at 4
h post-infection, compared to a maximum of 25% at 2 h post-infection. The highest anti-cytotoxic effect
was recorded when the antimicrobial mixture was present in the culture media at all time points during
infection. These results clearly show that the pre-treatment of the bacteria or of the epithelial cells
prior to infection will have a significant role in keeping the cytotoxicity levels reduced (∗∗∗ p < 0.001).
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4. Discussion
Natural antimicrobials are known to be effective in reducing bacterial pathogenicity via direct [13]
or indirect [26] anti-virulence activity. For example, the surface proteins involved in the virulence
of Staphylococcus aureus are inhibited by venom peptides from being promising candidates for the
treatment of related infections caused by multi-drug resistant bacteria [27] Quorum-sensing molecules
originating from marine bacteria can control virulence, with gene expression being described as a novel
antimicrobial strategy in aquaculture [28]. Another mechanism by which natural antimicrobials can
reduce virulence refers to their involvement in bacterial physiology, as it has been shown that phenolic
compounds can disrupt the expression and function of eﬄux pumps [29]. They can also reduce the
ability of bacterial pathogens to adhere to epithelial cells in vitro (e.g., Daphnetin, a coumarin-derivative)
by reducing the expression of H. pylori genes involved in colonisation [30]. Antimicrobial mixtures of
probiotics, organic acids and essential oils were effective in reducing the devastating impact of Vibrio
strain infections in South American farmed shrimps [31]; however, the study did not elucidate the
biological mechanism responsible for the effect.
V. parahaemolyticus is often found in estuaries and coastal waters and because it causes severe
disease is also of significant importance as a human pathogen [32]. Phage and probiotic treatments
were proposed as alternative method to control infections in humans and aquaculture [23,33]. Constant
and un-controlled application of increased concentrations of antibiotics in aquatic environments
lead to increased resistance in the bacterial populations (e.g., V. parahaemolyticus), posing a threat to
human and animal health and is of major concern to fish and shellfish farmers [34,35]. Early mortality
syndrome is caused by infection with V. parahaemolyticus and strains A3 and D4 [36] were previously
reported to affect shrimp farming by causing the acute hepatopancreatic necrosis disease (AHPND) [37].
V. parahaemolyticus strains A3 and D4 [3] acquired the type VI secretions system (T6SS), offering them
a competitive advantage in survival and virulence over other bacteria in the shrimp ecosystem [7].
This development increases the need for effective control measures to prevent infection of fish and
shellfish farms, especially by preventing the multiplication and virulence of V. parahaemolyticus in such
environments [38].
Natural antimicrobials offer such an opportunity by being known to affect bacterial cell
membranes [39]. One such example is lavender extract, which has previously been shown to
reduce the ability of V. parahaemolyticus to produce and release its toxin [40]. The anti-virulent effect
of natural antimicrobial mixtures was previously described in other pathogens e.g., Campylobacter
jejuni, Campylobacter coli and Shiga Toxin Producing E. Coli (STEC) [13,41]. This anti-virulent effect was
exhibited by decreasing the activity of major virulence factors including motility, and by reducing the
in vitro and in vivo infection abilities, T6SS and biofilm formation [13,42].
According to our results, such mixtures can be used efficiently in both fresh and marine water
environments, as we have observed similar results in low and high salt conditions. Similar antimicrobial
mixtures have been previously used to prevent the bacterial infection of epithelial cells, both in vitro
and in vivo [13], through the inactivation of virulence factors. The link between T6SS inactivation and
decreased virulence has been previously shown, as it has been indicated that its presence enhances the
adhesion to cultured cell monolayers [43]. This proposed hypothesis has been previously described for
C. jejuni RC039, where the downregulation of the hcp gene was associated with reduced virulence both
in vitro and in vivo [13].
In addition, V. parahaemolyticus A3 and D4 appear to stimulate H2O2 release from human intestinal
epithelial cells, possibly by altering the redox balance within the host’s lumen or by triggering the host
NADPH oxidases. Microbiota-induced alterations to the lumen redox balance could have a modulatory
effect upon pathogenicity, favoring the intestinal pathogen [24]. Therefore, our results indicate that a
suitable antimicrobial mixture (e.g., A3009) could be used to maintain the intestinal redox balance by
restricting H2O2 release. However, the presence of hydrogen peroxide during the interaction between
V. parahaemolyticus and the host epithelium does not seem to be critical, since it is able to significantly
express catalase enzymes and induce a detoxification process [44].
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5. Conclusions
The data presented herein describe the effect of a mixture of antimicrobials (A3009) on the virulence
and pathogenicity of T6SS V. parahaemolyticus A3 and D4 strains. The antimicrobials reduced the ability
of V. parahaemolyticus A3 and D4 to infect the CHSE-214 fish cell line by inhibiting the expression of
the T6SS hcp1 and hcp2 genes and through the reduction of bacterial motility in both low and high
salt environments. These results corroborated with the antioxidant effect, low tissue cytotoxicity and
the low mortality recorded in the in vivo challenge test, suggesting that this antimicrobial mixture
(A3009) can be efficiently used to improve the survival of shrimp populations when subject to
V. parahaemolyticus infections.
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